| Design, synthesis, docking, DFT, MD simulation studies of a new nicotinamide-based derivative: In vitro anticancer and VEGFR-2 inhibitory effects EB Elkaeed, RG Yousef, H Elkady, IMM Gobaara, BA Alsfouk, DZ Husein, ... Molecules 27 (14), 4606, 2022 | 74 | 2022 |
| Distance education during COVID-19 pandemic: A college of pharmacy experience N Altwaijry, A Ibrahim, R Binsuwaidan, LI Alnajjar, BA Alsfouk, R Almutairi Risk Management and Healthcare Policy, 2099-2110, 2021 | 64 | 2021 |
| Tolerability of antiseizure medications in individuals with newly diagnosed epilepsy BAA Alsfouk, MJ Brodie, M Walters, P Kwan, Z Chen JAMA neurology 77 (5), 574-581, 2020 | 54 | 2020 |
| Ligand and Structure-Based In Silico Determination of the Most Promising SARS-CoV-2 nsp16-nsp10 2′-o-Methyltransferase Complex Inhibitors among 3009 … IH Eissa, MS Alesawy, AM Saleh, EB Elkaeed, BA Alsfouk, AAMM El-Attar, ... Molecules 27 (7), 2287, 2022 | 39 | 2022 |
| New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-proliferative activity, docking, ADMET, toxicity, and MD simulation studies EB Elkaeed, MS Taghour, HA Mahdy, WM Eldehna, NM El-Deeb, ... Journal of Enzyme Inhibition and Medicinal Chemistry 37 (1), 2191-2205, 2022 | 35 | 2022 |
| Multi-phase in silico discovery of potential SARS-CoV-2 RNA-dependent RNA polymerase inhibitors among 3009 clinical and FDA-approved related drugs EB Elkaeed, H Elkady, A Belal, BA Alsfouk, TH Ibrahim, M Abdelmoaty, ... Processes 10 (3), 530, 2022 | 34 | 2022 |
| Design, synthesis, anti-proliferative evaluation, docking, and MD simulations studies of new thiazolidine-2, 4-diones targeting VEGFR-2 and apoptosis pathway MS Taghour, H Elkady, WM Eldehna, N El-Deeb, AM Kenawy, ... PLoS One 17 (9), e0272362, 2022 | 31 | 2022 |
| Jusanin, a New Flavonoid from Artemisia commutata with an In Silico Inhibitory Potential against the SARS-CoV-2 Main Protease YM Suleimen, RA Jose, RN Suleimen, C Arenz, MY Ishmuratova, ... Molecules 27 (5), 1636, 2022 | 28 | 2022 |
| New theobromine derivative as apoptotic anti-triple-negative breast cancer targeting EGFR protein: CADD story IH Eissa, RG Yousef, H Elkady, EB Elkaeed, DZ Husein, IM Ibrahim, ... Journal of Molecular Structure 1294, 136336, 2023 | 25 | 2023 |
| Anti-cancer and immunomodulatory evaluation of new nicotinamide derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: in vitro and in silico studies RG Yousef, A Elwan, IMM Gobaara, ABM Mehany, WM Eldehna, ... Journal of Enzyme Inhibition and Medicinal Chemistry 37 (1), 2206-2222, 2022 | 23 | 2022 |
| In silico, in vitro VEGFR-2 inhibition, and anticancer activity of a 3-(hydrazonomethyl)naphthalene-2-ol derivative EB Elkaeed, RG Yousef, H Elkady, ABM Mehany, BA Alsfouk, DZ Husein, ... Journal of Biomolecular Structure and Dynamics 41 (16), 7986-8001, 2023 | 21 | 2023 |
| Discovery of new VEGFR-2 inhibitors: design, synthesis, anti-proliferative evaluation, docking, and MD simulation studies EB Elkaeed, RG Yousef, MM Khalifa, A Ibrahim, ABM Mehany, ... Molecules 27 (19), 6203, 2022 | 18 | 2022 |
| The Computational Preventive Potential of the Rare Flavonoid, Patuletin, Isolated from Tagetes patula, against SARS-CoV-2 AM Metwaly, EB Elkaeed, BA Alsfouk, AM Saleh, AE Mostafa, IH Eissa Plants 11 (14), 1886, 2022 | 18 | 2022 |
| Characteristics and treatment outcomes of newly diagnosed epilepsy in older people: A 30‐year longitudinal cohort study BAA Alsfouk, H Hakeem, Z Chen, M Walters, MJ Brodie, P Kwan Epilepsia 61 (12), 2720-2728, 2020 | 17 | 2020 |
| Discovery of new quinoline and isatine derivatives as potential VEGFR-2 inhibitors: Design, synthesis, antiproliferative, docking and MD simulation studies MS Taghour, H Elkady, WM Eldehna, N El-Deeb, AM Kenawy, ... Journal of Biomolecular Structure and Dynamics 41 (21), 11535-11550, 2023 | 14 | 2023 |
| Isolation and In Silico Inhibitory Potential against SARS-CoV-2 RNA Polymerase of the Rare Kaempferol 3-O-(6″-O-acetyl)-Glucoside from Calligonum tetrapterum YM Suleimen, RA Jose, GK Mamytbekova, RN Suleimen, MY Ishmuratova, ... Plants 11 (15), 2072, 2022 | 14 | 2022 |
| Pharmacological outcomes in teenagers with newly diagnosed epilepsy: A 30‐year cohort study BA Alsfouk, AA Alsfouk, Z Chen, P Kwan, MJ Brodie Epilepsia 60 (6), 1083-1090, 2019 | 14 | 2019 |
| A new anticancer semisynthetic theobromine derivative targeting EGFR protein: CADDD study IH Eissa, RG Yousef, H Elkady, AA Alsfouk, BA Alsfouk, DZ Husein, ... Life 13 (1), 191, 2023 | 11 | 2023 |
| Design, synthesis, in silico and in vitro studies of new immunomodulatory anticancer nicotinamide derivatives targeting VEGFR-2 RG Yousef, WM Eldehna, A Elwan, AS Abdelaziz, ABM Mehany, ... Molecules 27 (13), 4079, 2022 | 11 | 2022 |
| Discovery of new VEGFR-2 inhibitors and apoptosis inducer-based thieno[2,3-d]pyrimidine SA El-Metwally, H Elkady, M Hagras, EB Elkaeed, BA Alsfouk, ... Future Medicinal Chemistry 15 (22), 2065-2086, 2023 | 10 | 2023 |
